UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer

Annals of oncology, 2020-12, Vol.31 (12), p.1725-1733

2020

Volltextzugriff (PDF)

FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma

Annals of oncology, 2018-10, Vol.29 (10), p.2115-2120

2018

Volltextzugriff (PDF)

FDG-PET to predict long-term outcome from anti-PD-1 therapy in metastatic melanoma

Annals of oncology, 2022-01, Vol.33 (1), p.99-106

2022

Volltextzugriff (PDF)

165 RNAi Screen Identifies ATM-directed Metabolic Pathway as Synthetic Lethal with FLT3 Inhibition in AML

European journal of cancer (1990), 2012-11, Vol.48, p.50-51

2012

Volltextzugriff (PDF)

Dutch Chronic Pancreatitis Registry (CARE): Design and rationale of a nationwide prospective evaluation and follow-up

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2015-01, Vol.15 (1), p.46-52

2015

Volltextzugriff (PDF)

375 MER as a novel therapeutic target in colorectal cancer

European journal of cancer (1990), 2014-11, Vol.50, p.120-121

2014

Volltextzugriff (PDF)

393 TAK-733, an Investigational Novel MEK Inhibitor, Suppresses Colorectal Cancer (CRC) Tumor Growth in Biomarker Positive Patient-derived Human Tumor Explants

European journal of cancer (1990), 2012-11, Vol.48, p.119-120

2012

Volltextzugriff (PDF)

485 Targeting the MAP Kinase and Wnt Signaling Pathways in Preclinical Models of Colorectal Cancer

European journal of cancer (1990), 2012-11, Vol.48, p.150-150

2012

Volltextzugriff (PDF)

562 Antitumor Activity of the Polo-like Kinase (PLK) Inhibitor, TAK-960, Alone and in Combination with Standard Agents Against KRAS WT and MT Colorectal Cancer (CRC) Models

European journal of cancer (1990), 2012-11, Vol.48, p.172-173

2012

Volltextzugriff (PDF)

254 In Vitro and in Vivo Antitumor Activity of the Investigational Aurora A Selective Kinase Inhibitor MLN8237 Alone and in Combination with Standard Agents Against CRC Models

European journal of cancer (1990), 2012-11, Vol.48, p.78-78

2012

Volltextzugriff (PDF)

255 Molecular Markers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Human Colorectal Cancer (CRC) Models

European journal of cancer (1990), 2012-11, Vol.48, p.78-78

2012

Volltextzugriff (PDF)

1054P FDG-PET to predict long-term outcome from anti-PD1 (PD1) therapy in metastatic melanoma

Annals of oncology, 2021-09, Vol.32, p.S880-S880

2021

Volltextzugriff (PDF)

P2.09-01 A Large Asian Real-World EGFR exon 20Insertion Mutated NSCLC Dataset with Deep Genomic Characterization

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S330

2023

Volltextzugriff (PDF)

P3.03I.06 Neoadjuvant Gefitinib in EGFR Mutated NSCLC (a Phase 2 Window-Of-Opportunity Study): Deep Genomic and Transcriptomic Analysis

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S311-S311

2024

Volltextzugriff (PDF)

P2.10-03 Mechanisms of Acquired Resistance to ALK Inhibitors Using Plasma Sequencing - Preliminary Data from the ATORG004 Study

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S352-S353

2023

Volltextzugriff (PDF)

Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group

ESMO open, 2023-08, Vol.8 (4), p.101586-101586, Article 101586

2023

Volltextzugriff (PDF)

Sa1136 – Detection of Barrett's Esophagus Through Exhaled Breath Using a Non-Invasive Screening Tool

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-280-S-280

2019

Volltextzugriff (PDF)

Molecular profiling of non-small cell lung cancer (NSCLC) in Asia with targeted next-generation sequencing (NGS): Interim analysis of a co-operative group study (ATORG-001)

Annals of oncology, 2019-11, Vol.30, p.ix126

2019

Volltextzugriff (PDF)

A phase I study of varlitinib (VAR; ASLAN001) an oral pan-HER tyrosine kinase inhibitor (TKI) combined with mFOLFIRI chemotherapy in advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v178

2019

Volltextzugriff (PDF)

472P - A phase I study of varlitinib (VAR; ASLAN001) an oral pan-HER tyrosine kinase inhibitor (TKI) combined with mFOLFIRI chemotherapy in advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v178-v178

2019

Volltextzugriff (PDF)

85O Low-pass whole genome sequencing (lpWGS) to quantify circulating tumor DNA (ctDNA) burden as a pharmacodynamic response biomarker in patients on early phase trials

ESMO open, 2024-02, Vol.9, p.102311, Article 102311

2024

Volltextzugriff (PDF)

Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia

Leukemia, 2012-06, Vol.26 (6), p.1266-1276

2012

Volltextzugriff (PDF)

GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems

Journal of dental research, 2018-07, Vol.97 (8), p.909-916

2018

Volltextzugriff (PDF)

Trials without borders—decentralized trials and ensuring access to novel cancer therapies during a global pandemic

ESMO open, 2022-08, Vol.7 (4), p.100537-100537, Article 100537

2022

Volltextzugriff (PDF)

Microbiology and Antimicrobial Therapy in (Infected) Necrotizing Pancreatitis: A Prospective Observational Cohort Study

HPB (Oxford, England), 2022, Vol.24, p.S243-S243

2022

Volltextzugriff (PDF)

1 – 25 von 282

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(252)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(167)
Life Sciences & Biomedicine
(100)
Humans
(69)
Technology
(59)
Engineering
(39)
Female
(39)
Male
(37)
Engineering, Electrical & Electronic
(29)
Middle Aged
(29)
Biological And Medical Sciences
(26)
Aged
(25)
Physical Sciences
(25)
Adult
(23)
Exact Sciences And Technology
(23)
Materials Science
(20)
Applied Sciences
(19)
Oncology
(18)
Materials Science, Multidisciplinary
(16)
Medical Sciences
(16)
Physics
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer

FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma

FDG-PET to predict long-term outcome from anti-PD-1 therapy in metastatic melanoma

165 RNAi Screen Identifies ATM-directed Metabolic Pathway as Synthetic Lethal with FLT3 Inhibition in AML

Dutch Chronic Pancreatitis Registry (CARE): Design and rationale of a nationwide prospective evaluation and follow-up

375 MER as a novel therapeutic target in colorectal cancer

393 TAK-733, an Investigational Novel MEK Inhibitor, Suppresses Colorectal Cancer (CRC) Tumor Growth in Biomarker Positive Patient-derived Human Tumor Explants

485 Targeting the MAP Kinase and Wnt Signaling Pathways in Preclinical Models of Colorectal Cancer

562 Antitumor Activity of the Polo-like Kinase (PLK) Inhibitor, TAK-960, Alone and in Combination with Standard Agents Against KRAS WT and MT Colorectal Cancer (CRC) Models

254 In Vitro and in Vivo Antitumor Activity of the Investigational Aurora A Selective Kinase Inhibitor MLN8237 Alone and in Combination with Standard Agents Against CRC Models

255 Molecular Markers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Human Colorectal Cancer (CRC) Models

1054P FDG-PET to predict long-term outcome from anti-PD1 (PD1) therapy in metastatic melanoma

P2.09-01 A Large Asian Real-World EGFR exon 20Insertion Mutated NSCLC Dataset with Deep Genomic Characterization

P3.03I.06 Neoadjuvant Gefitinib in EGFR Mutated NSCLC (a Phase 2 Window-Of-Opportunity Study): Deep Genomic and Transcriptomic Analysis

P2.10-03 Mechanisms of Acquired Resistance to ALK Inhibitors Using Plasma Sequencing - Preliminary Data from the ATORG004 Study

Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group

Sa1136 – Detection of Barrett's Esophagus Through Exhaled Breath Using a Non-Invasive Screening Tool

Molecular profiling of non-small cell lung cancer (NSCLC) in Asia with targeted next-generation sequencing (NGS): Interim analysis of a co-operative group study (ATORG-001)

A phase I study of varlitinib (VAR; ASLAN001) an oral pan-HER tyrosine kinase inhibitor (TKI) combined with mFOLFIRI chemotherapy in advanced solid tumours

472P - A phase I study of varlitinib (VAR; ASLAN001) an oral pan-HER tyrosine kinase inhibitor (TKI) combined with mFOLFIRI chemotherapy in advanced solid tumours

85O Low-pass whole genome sequencing (lpWGS) to quantify circulating tumor DNA (ctDNA) burden as a pharmacodynamic response biomarker in patients on early phase trials

Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia

GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems

Trials without borders—decentralized trials and ensuring access to novel cancer therapies during a global pandemic

Microbiology and Antimicrobial Therapy in (Infected) Necrotizing Pancreatitis: A Prospective Observational Cohort Study

Suchergebnisse filtern